Physician profile
Goretti Taghva
NPI 1538399001
$11,889.13
in general payments reported to CMS, 2019-2025
16 companies · $6,109 in 2025
The $6,109 reported for 2025 was more than what 93% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $2,430 · 2021: $147 · 2022: $182 · 2023: $102 · 2024: $2,162 · 2025: $6,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,914 · Food and Beverage: $3,460.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,913.66 |
| Food and Beverage | $3,459.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $5,661.85 | 2019-2025 | |
| Mentor Worldwide LLC | $2,542.77 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Lumenis Be INC | $1,935.64 | 2024 | M22 |
| Galderma Laboratories, L.P. | $575.40 | 2019-2024 | |
| Sientra, INC. | $285.93 | 2019-2022 | |
| Revance Therapeutics, INC. | $269.29 | 2024-2025 | Daxxify |
| Abbvie INC. | $134.50 | 2023-2025 | |
| Medtronic, INC. | $91.34 | 2021-2022 | |
| Solta Medical, A Division of Bausch Health US, LLC | $88.37 | 2019-2025 | |
| Globus Medical, INC. | $82.16 | 2025 | Mars |
| Musculoskeletal Transplant Foundation INC. | $51.81 | 2019-2025 | |
| Allergan, INC. | $46.65 | 2020-2021 | |
| Nevro Corp. | $44.63 | 2020-2023 | Senza |
| Cumberland Pharmaceuticals, INC. | $39.89 | 2025 | Caldolor |
| Integra Lifesciences Corporation | $21.50 | 2023 | Durasorb Monofilament Mesh |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $17.40 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Goretti Taghva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.